Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiao'er Kechuan Granules in Pediatric Cough Variant Asthma
CTR20150213Phase 2Terminated
- Sponsor
- Beijing Huikang Century Biotechnology Consulting
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xiao'er Kechuan Granules in cough variant asthma (CVA), sponsored by Beijing Huikang Century Biotechnology Consulting. Started Jan 2022; status: terminated.
02
Drugs
Xiao'er Kechuan Granules
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20150213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150213.